The Impact of Testosterone Therapy on the Vaginal Microbiota of Transgender Men and Nonbinary People: A Prospective Study
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiaf114 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Olivia T Van Gerwen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Testosterone, Vagina, Transgender Persons, Microbiota. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Background
Understanding the impact of testosterone on the vaginal microbiota of transgender men (TGM) and nonbinary people assigned female sex at birth over time is imperative as vaginal dysbiosis and incident bacterial vaginosis (iBV) may cause bothersome genital symptoms and increase human immunodeficiency virus/sexually transmitted infection (HIV/STI) acquisition risk. We investigated shifts in the composition of the vaginal microbiota over time in TGM initiating testosterone for gender-affirming hormone therapy, including development of vaginal dysbiosis and iBV.
Methods
Participants ages ≥18 years, assigned female sex at birth and reporting TGM or nonbinary identity, interested in starting injectable testosterone, demonstrating optimal vaginal microbiota, with no current STI(s) were enrolled. Participants self-collected daily vaginal specimens for 7 days prior to testosterone initiation and 90 days thereafter for vaginal Gram staining and 16S rRNA gene sequencing. Episodes of vaginal dysbiosis and iBV were defined as Nugent scores ≥4 or ≥7, respectively, each for ≥2 consecutive days.
Results
Between February 2022 and November 2023, 9 participants enrolled, 89% (8/9) developed ≥1 episode(s) of vaginal dysbiosis after testosterone initiation, and 56% (5/9) developed iBV. Among those who developed iBV, most did so between days 20 and 40 after testosterone initiation. Community state type (CST) I was found most often in participants who did not develop iBV and CST IV-B most often in participants who developed iBV. Sexual activity and menses also appeared to influence the development of iBV.
Conclusions
The majority of participants developed vaginal dysbiosis including iBV. Additional studies with larger sample sizes are needed to further elucidate how testosterone impacts the vaginal microbiota.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Division of Endocrinology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Center for Clinical and Translational Sciences, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
ORCID-Profile: Olivia T Van Gerwen, Kristal J Aaron, Emma Sophia Kay, David E Nelson, Christina A Muzny
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Van Gerwen, O. T., Aaron, K. J., Kay, E. S., Siwakoti, K., Pontius, A., Richter, S., Sherman, Z. A., Graves, K. J., Tamhane, A., Elnaggar, J. H., Luo, M., Toh, E., Nelson, D. E., Van Wagoner, N. J., Taylor, C. M., & Muzny, C. A. (2025). The Impact of Testosterone Therapy on the Vaginal Microbiota of Transgender Men and Nonbinary People: A Prospective Study. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf114
Vancouver
Van Gerwen OT, Aaron KJ, Kay ES, Siwakoti K, Pontius A, Richter S, et al. The Impact of Testosterone Therapy on the Vaginal Microbiota of Transgender Men and Nonbinary People: A Prospective Study. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf114
BibTeX
@article{VanGerwen2025,
author = {Van Gerwen, Olivia T and Aaron, Kristal J and Kay, Emma Sophia and Siwakoti, Krishmita and Pontius, Angela and Richter, Saralyn and Sherman, Z Alex and Graves, Keonte J and Tamhane, Ashutosh and Elnaggar, Jacob H and Luo, Meng and Toh, Evelyn and Nelson, David E and Van Wagoner, Nicholas J and Taylor, Christopher M and Muzny, Christina A},
title = {The Impact of Testosterone Therapy on the Vaginal Microbiota of Transgender Men and Nonbinary People: A Prospective Study},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiaf114}
}
EUVIMED